{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T03:52:52Z","timestamp":1782359572472,"version":"3.54.5"},"reference-count":0,"publisher":"International Institute of Anticancer Research","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AR"],"published-print":{"date-parts":[[2018,5,2]]},"DOI":"10.21873\/anticanres.12536","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T17:27:19Z","timestamp":1525282039000},"source":"Crossref","is-referenced-by-count":6,"title":["Disparities of Immunotherapy Utilization in Patients with Stage III Cutaneous Melanoma: A National Perspective"],"prefix":"10.21873","volume":"38","member":"9336","container-title":["Anticancer Research"],"original-title":[],"deposited":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T17:27:39Z","timestamp":1525282059000},"score":1,"resource":{"primary":{"URL":"http:\/\/ar.iiarjournals.org\/content\/38\/5\/2897.abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5,2]]}},"URL":"https:\/\/doi.org\/10.21873\/anticanres.12536","relation":{},"ISSN":["0250-7005","1791-7530"],"issn-type":[{"value":"0250-7005","type":"print"},{"value":"1791-7530","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]}}}